초음파 내시경(EUS) 시장 규모는 2023년에 14억 4,000만 달러로 평가되었고 2029년까지 복합 연간 성장률(CAGR) 7.21%로 예측 기간 중에 눈부신 성장이 전망되고 있습니다.
초음파 내시경(EUS)은 내시경 검사와 고주파 초음파를 결합한 신체 내 장기와 구조를 가시화하고 평가하기 위한 의료용 이미징 절차입니다. 주로 진단이나 병기 분류 외에 치료적 개입을 이끌 목적으로 사용됩니다. 검사는 먼저 내시경 검사로 시작합니다. 내시경은 광원과 카메라를 팁에 갖춘 플렉서블 튜브 모양의 도구입니다. 내시경은 입과 직장과 같은 신체의 자연적인 개구부 또는 작은 절개 창에서 도입됩니다. 내시경은 체내를 직접 시각화 할 수 있습니다. EUS에서 사용되는 내시경의 끝에는 초음파 트랜스듀서(프로브)가 장착되어 있습니다. 이 트랜스듀서는 인간의 가청 영역을 넘는 고주파 음파를 방출합니다. 이 음파는 체내를 전해, 다양한 조직이나 구조를 만나면 에코로서 튕겨 옵니다. 에코는 트랜스듀서에서 수신되어 실시간 초음파 이미지로 변환됩니다. 이 이미지는 모니터에 표시되며 장기, 중공 장기(소화관과 같은) 벽, 혈관, 림프절 및 기타 구조를 자세히 볼 수 있습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2025-2029 |
| 시장 규모 : 2023년 | 14억 4,000만 달러 |
| 시장 규모 : 2029년 | 21억 9,000만 달러 |
| 복합 연간 성장률(CAGR) : 2024년-2029년 | 7.21% |
| 급성장 부문 | 내시경 |
| 최대 시장 | 북미 |
EUS의 화질 향상, 기구의 소형화, 인공지능의 응용 등 지속적인 기술 혁신에 의해 진단 정밀도가 향상되어 치료 응용의 폭이 넓어지고 있습니다. 환자와 의료 제공업체들 사이에서 침습 수술에 대한 선호도가 높아지고 있으며, EUS는 특정 질병에 대한 전통적인 수술을 대체하는 더 침습적 인 선택을 제공합니다. 세계 고령화는 췌장암 등 EUS를 필요로 하는 질환의 발생률의 상승과 관련되어 있습니다. 이 인구 동향은 시장 성장의 주요 촉진요인입니다. 특히 EUS가 그다지 일반적으로 수행되지 않는 지역에서의 건강 관리 상환 정책의 개선으로 인해, EUS는 환자에게 보다 이용하기 쉬워지고, 의료 제공업체에게는 경제적으로 실현 가능한 절차가 되고 있습니다. EUS는 췌장낭종, 위장관 종양, 폐암과 같은 질병의 조기 진단 및 저침습 치료 옵션에 도움이 되어 환자의 예후를 개선합니다.
EUS 기술의 발전
조기 진단 및 치료 증가
시장 경쟁 격화와 기술 혁신
높은 초기 비용
경쟁 및 시장 포화 상태
낮은 침습 수술 증가
Global Endoscopic Ultrasound Market was valued at USD 1.44 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 7.21% through 2029. Endoscopic Ultrasound (EUS) is a medical imaging procedure that combines endoscopy with high-frequency ultrasound to visualize and assess internal organs and structures within the body. It is primarily used for diagnostic and staging purposes, as well as for guiding therapeutic interventions. The procedure begins with endoscopy. An endoscope is a flexible, tube-like instrument with a light source and a camera at its tip. The endoscope is introduced through a natural opening in the body, such as the mouth or rectum, or through a small incision. It allows direct visualization of the inside of the body. The endoscope used in EUS is equipped with an ultrasound transducer (probe) at its tip. This transducer emits high-frequency sound waves, which are beyond the range of human hearing. These sound waves travel through the body and bounce back as echoes when they encounter different tissues and structures. The echoes are received by the transducer and converted into real-time ultrasound images. These images are displayed on a monitor and provide a detailed view of the organs, walls of hollow organs (like the gastrointestinal tract), blood vessels, lymph nodes, and other structures.
| Market Overview | |
|---|---|
| Forecast Period | 2025-2029 |
| Market Size 2023 | USD 1.44 Billion |
| Market Size 2029 | USD 2.19 Billion |
| CAGR 2024-2029 | 7.21% |
| Fastest Growing Segment | Endoscope |
| Largest Market | North America |
Ongoing technological innovations, including improved image quality, miniaturized instruments, and artificial intelligence applications in EUS, are enhancing diagnostic accuracy, and expanding the range of therapeutic applications. There is a growing preference for minimally invasive procedures among patients and healthcare providers, and EUS offers a less invasive alternative to traditional surgeries for certain conditions. The global aging population is associated with an increased incidence of conditions that require EUS, such as pancreatic cancer. This demographic trend is a significant driver of market growth. Improvements in healthcare reimbursement policies, particularly in regions where EUS is less commonly practiced, have made these procedures more accessible to patients and financially viable for healthcare providers. EUS aids in early diagnosis and minimally invasive treatment options for conditions like pancreatic cysts, gastrointestinal tumors, and lung cancer, resulting in better patient outcomes.
Key Market Drivers
Advancements in EUS Technology
EUS equipment has seen significant improvements in image quality. High-resolution ultrasound and enhanced imaging technologies provide clearer and more detailed images of internal organs, tissues, and lesions. This helps in precise diagnosis and staging of diseases. EUS instruments have become more compact and portable, making them easier to handle during procedures. Miniaturized scopes and probes can be inserted through smaller channels, reducing patient discomfort and recovery time. The development of advanced ultrasound probes, including radial and linear-array transducers, offers greater flexibility in imaging and improved visualization of specific anatomical structures. These probes provide various viewing angles for comprehensive assessments. Elastography is an emerging technology in EUS that measures tissue stiffness. It can help differentiate between benign and malignant lesions by assessing tissue elasticity. This is particularly valuable in the evaluation of pancreatic masses.
The use of contrast agents during EUS procedures has become more common. Contrast-enhanced imaging allows for better visualization of blood vessels and perfusion within lesions, aiding in the differentiation of various tissue types. Fine-needle aspiration (FNA) and fine-needle biopsy (FNB) techniques have evolved with the development of specialized needles. These needles offer improved sample collection, reducing the need for multiple passes and enhancing diagnostic accuracy. Integration of real-time image processing and computer-aided diagnostic tools helps healthcare professionals analyze EUS images more effectively. This technology can assist in lesion characterization and identifying abnormal tissue. AI and machine learning algorithms are being applied to EUS to assist in image interpretation, automated lesion detection, and prediction of disease outcomes. These technologies enhance diagnostic capabilities and reduce the risk of human error.
EUS is progressing towards three-dimensional (3D) and four-dimensional (4D) imaging, providing volumetric data that can improve the understanding of complex anatomical structures and aid in surgical planning. EUS navigation systems, combined with fusion imaging techniques, enable the integration of EUS images with other imaging modalities such as CT and MRI. This assists in precise localization and targeting during interventions. Robotic systems are being explored in the field of EUS, allowing for enhanced dexterity and precision during procedures. Robot-assisted EUS can potentially improve the safety and accuracy of interventions. Telemedicine and remote guidance technologies have made it possible for experts to remotely guide and assist less experienced healthcare providers in performing EUS procedures, particularly in underserved or remote areas. This factor will help in the development of the Global Endoscopic Ultrasound Market.
Rising Early Diagnosis and Treatment
Early diagnosis allows for the timely initiation of appropriate treatment. For conditions like cancer, early detection can significantly improve the chances of successful treatment and long-term survival. Patients and healthcare providers seek tools like EUS that can provide accurate and early diagnoses. EUS is a valuable tool for staging various types of cancer, including pancreatic, esophageal, and lung cancers. Early and accurate cancer staging is vital for determining the extent of the disease and planning the most effective treatment strategy, which often includes surgery, chemotherapy, or radiation therapy. EUS is a minimally invasive procedure, making it a preferable option for patients who are concerned about the invasiveness and risks associated with surgical interventions. Early diagnosis, when followed by minimally invasive treatment, can lead to shorter hospital stays and faster recovery times. EUS is used in cancer screening and surveillance programs for individuals at high risk for certain cancers. Early detection can lead to the identification of precancerous lesions or early-stage cancers, allowing for interventions that can prevent cancer development or lead to more successful treatment outcomes. EUS-guided fine-needle aspiration (FNA) and fine-needle biopsy (FNB) allow for the collection of tissue samples for pathological examination. Early access to tissue samples can lead to a prompt and accurate diagnosis, enabling healthcare providers to tailor treatments to the specific characteristics of the disease.
Early diagnosis helps in halting or slowing the progression of diseases. By detecting and treating conditions at an earlier stage, EUS can reduce the risk of complications and the need for more aggressive or invasive treatments. Early detection often results in less aggressive treatment strategies, which can be less taxing on the patient's body and result in a higher quality of life during and after treatment. For patients, early diagnosis provides peace of mind and a sense of control over their health. It can alleviate anxiety associated with uncertainty about the nature and extent of their condition. Early diagnosis and treatment can be cost-effective, as it may reduce the need for costly and extensive treatments that would be required for more advanced disease stages. Early diagnosis and treatment can lead to reduced healthcare system costs by preventing complications and reducing the burden on healthcare facilities. It can also free up resources for other patients. This factor will pace up the demand of the Global Endoscopic Ultrasound Market.
Increasing Market Competition and Innovation
Intense market competition encourages medical device manufacturers to innovate and improve their EUS equipment. This leads to the development of more advanced and efficient EUS technology, including high-definition imaging, advanced probes, and enhanced user interfaces. Ongoing innovation in EUS technology has broadened its clinical applications. New and improved EUS equipment enables the diagnosis and management of a wider range of medical conditions, such as pancreatic cysts, subepithelial lesions, and even obesity treatment. Innovative EUS procedures and equipment can lead to better patient outcomes. Enhanced imaging capabilities improved diagnostic accuracy, and the availability of new therapeutic techniques contribute to improved treatment results. Innovative EUS technology allows for faster and more efficient procedures, reducing the time patients spend in diagnostic or treatment settings. This increased efficiency benefits both patients and healthcare facilities.
Market competition encourages the development of patient centric EUS solutions. These innovations aim to enhance patient comfort and convenience, making the procedure more accessible and tolerable for a wider range of individuals. Increased competition can lead to more cost-effective EUS solutions, making the technology more accessible to healthcare providers and patients. Cost reductions may be achieved through more efficient equipment design and manufacturing processes. Competition often drives the expansion of EUS services into new regions and healthcare facilities. As more providers offer EUS procedures, patient access to this technology increases, driving demand. The need to stay competitive prompts medical device manufacturers and healthcare institutions to invest in training and education programs for healthcare professionals. These programs ensure that medical staff are proficient in using the latest EUS equipment and techniques. Competitive companies often seek to expand their market reach beyond their home region, fostering the global growth of EUS technology and increasing its availability to healthcare providers and patients worldwide. Market competition often pushes manufacturers to meet or exceed regulatory and quality standards, resulting in safer and more reliable EUS equipment. This factor will accelerate the demand of the Global Endoscopic Ultrasound Market
Key Market Challenges
High Initial Costs
Hospitals, clinics, and healthcare institutions that wish to provide EUS services must make substantial investments in acquiring EUS equipment, including ultrasound machines, endoscopes, and specialized accessories. These initial costs can strain their budgets. Healthcare professionals, particularly Endo sonographers and gastroenterologists, require specialized training to perform EUS procedures effectively and safely. The costs associated with training programs and ongoing education can be significant. Ongoing maintenance, calibration, and repairs of EUS equipment add to the overall cost of ownership. Ensuring that the equipment is in optimal condition is crucial for delivering high-quality patient care. Keeping up with technological advancements in EUS often requires the regular replacement or upgrade of equipment. Staying at the forefront of EUS technology can result in substantial costs. Patients may face higher out-of-pocket expenses for EUS procedures, especially in regions with limited insurance coverage or high deductibles. These costs can be a barrier to accessing necessary diagnostic and treatment services. EUS procedures involve the use of specialized disposable accessories, such as fine-needle aspiration needles and ultrasound probes. The recurring cost of these consumables can add up over time.
Competition and Market Saturation
In highly competitive markets, EUS providers may need to specialize or focus on specific clinical applications or patient demographics to differentiate themselves. Market segmentation can lead to a more fragmented EUS market with specialized providers. Intense competition can drive innovation and improvements in the quality of EUS equipment and services. Providers and manufacturers strive to differentiate themselves by offering cutting-edge technology and better patient outcomes. High competition can make it challenging for new entrants to establish themselves in the EUS market. Existing players often have established reputations and customer bases, making it difficult for newcomers to gain a foothold. In some mature markets, EUS services may become saturated, with a high number of providers serving a relatively stable patient population. Market saturation can limit the growth potential for existing providers. Competition can lead to lower profit margins for EUS providers. Reduced margins may limit their ability to invest in new equipment, technology, or training, which could impact the quality of care provided. Highly competitive markets may place financial pressures on EUS providers, especially in regions with healthcare reimbursement constraints. These economic pressures can affect the financial sustainability of EUS services.
Key Market Trends
Rise in Minimally Invasive Procedures
Patients often prefer minimally invasive procedures over traditional open surgeries due to reduced pain, shorter recovery times, and smaller incisions or no incisions at all. Minimally invasive procedures, including EUS, can lead to better patient outcomes. They are associated with lower rates of complications, reduced post-operative pain, and shorter hospital stays. EUS is a minimally invasive procedure that provides high-resolution imaging and the ability to collect tissue samples for diagnosis. It is particularly valuable for conditions such as pancreatic cancer, gastrointestinal tumors, and lung cancer. Minimally invasive procedures often result in cost savings for healthcare systems and patients. Shorter hospital stays and fewer complications lead to lower overall healthcare expenditures. Ongoing advancements in EUS technology have made these procedures even less invasive and more effective. Improved imaging, better tools, and real-time guidance have contributed to the growth of minimally invasive EUS. EUS is commonly used for the staging of various cancers, and it can guide minimally invasive treatments, such as tumor ablation, fine-needle aspirations, and drainage procedures, contributing to better outcomes. Minimally invasive procedures, including EUS, are often more convenient for patients. They may require shorter recovery times, result in smaller scars, and allow patients to return to their daily activities sooner.
Segmental Insights
Product Insights
In 2023, the Global Endoscopic Ultrasound Market largest share was held by endoscope segment and is predicted to continue expanding over the coming years. Endoscopes are versatile instruments used in various medical specialties, including gastroenterology, pulmonology, surgery, and oncology. They have a wide range of diagnostic and therapeutic applications, making them essential tools for healthcare professionals. Endoscopes allow healthcare providers to directly visualize internal organs, lesions, and tissues within the body. In the context of EUS, endoscopes enable clear imaging and the collection of tissue samples through fine-needle aspiration (FNA), which is crucial for diagnosing and staging various medical conditions. EUS procedures often involve the use of endoscopes for high-resolution ultrasound imaging in combination with traditional endoscopic visualization. This integration of endoscopy with ultrasound technology provides a comprehensive and precise assessment of various diseases, including gastrointestinal and pancreatic conditions. Endoscopic ultrasound procedures are minimally invasive, which is particularly important for patients. These procedures reduce patient discomfort, recovery time, and the risks associated with more invasive surgical methods. The use of endoscopes in EUS procedures requires specialized training and expertise, and many healthcare providers have skilled end sonographers and gastroenterologists who can perform these procedures with precision.
End-Use Insights
In 2023, the Global Endoscopic Ultrasound Market largest share was held by Hospitals & Clinics segment in the forecast period and is predicted to continue expanding over the coming years. Hospitals and clinics are medical facilities that offer a wide variety of healthcare services and treatments. EUS is a versatile diagnostic and therapeutic tool that can be used in various medical specialties, such as gastroenterology, oncology, pulmonology, and surgery. This versatility makes it an asset for these facilities. Hospitals and clinics, especially those in developed regions, have advanced medical infrastructure and equipment. EUS requires specialized equipment and skilled healthcare professionals, and hospitals and clinics are well-equipped to provide these resources. These facilities often have a larger pool of specialized healthcare professionals, including gastroenterologists, end sonographers, surgeons, and oncologists, who are trained in performing EUS procedures and interpreting the results accurately. Hospitals and clinics typically serve many patients, and many of these patients may require EUS for the diagnosis and staging of various medical conditions, including gastrointestinal and pulmonary diseases. The high patient volume naturally drives the demand for EUS procedures. Hospitals and clinics are capable of both diagnosing and treating a wide range of medical conditions. EUS can be used for diagnostic purposes, such as visualizing lesions and obtaining tissue samples through fine-needle aspiration, as well as for therapeutic interventions like draining fluid collections and performing pseudocyst drainage.
Regional Insights
The North America region dominates the Global Endoscopic Ultrasound Market in 2023. North America, particularly the United States and Canada, boasts a highly advanced and well-developed healthcare infrastructure. This includes state-of-the-art medical facilities and a robust network of healthcare providers, making it easier to adopt and integrate advanced medical technologies like EUS. North America has a history of early adoption of cutting-edge medical technologies. Healthcare professionals in the region are often early adopters of innovative medical equipment and procedures, including EUS, which has contributed to its widespread use. North America has a relatively high prevalence of gastrointestinal diseases, such as pancreatic cancer, which frequently require EUS for accurate diagnosis, staging, and treatment planning. The region's disease burden has driven the demand for EUS procedures. North America is home to a large pool of skilled and specialized healthcare professionals, including gastroenterologists and Endo sonographers who are well-trained in performing EUS procedures.
Boston Scientific Corporation
Medtronic Plc.
ConMed Corp.
Olympus Corporation
STERIS
SonoScape Medical Corp.
PENTEX Medical
FUJIFILM Corporation
Cook Group Incorporated.
In this report, the Global Endoscopic Ultrasound Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
United States
Canada
Mexico
China
India
South Korea
Australia
Japan
Germany
France
United Kingdom
Spain
Italy
Brazil
Argentina
Colombia
South Africa
Saudi Arabia
UAE
Company Profiles: Detailed analysis of the major companies presents in the Global Endoscopic Ultrasound Market.
Global Endoscopic Ultrasound Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Detailed analysis and profiling of additional market players (up to five).